Pharmaceutical Supply Chain
Today, pharma supply chains hold massive buckets of data, making it a rich place to establish analytical advantages for Pharma and Life Sciences companies -- to develop a comprehensive, analytical approach to optimize their supply chain and operational efficiencies. To meet the current industry challenges and increasing supply chain complexity, our experts can evolve your supply chain in three areas—enablement, effectiveness, and earnings.
Before pharma companies can analyze how effective their supply chain really is, they will need to have clear, end-to-end visibility of their global supply chains linking strategy, performance, management and risk. At a simple glance, this begins with basic metrics and reporting, as these tools provide the backbone of data for performance measurements. Enablement can occur in three areas:
Decisions can only be as good as the data coming through. We help you build effective supply chain with appropriate, consistent movement of data up and down the supply chain.
A positive working capital ratio is essential for pharma companies to be able to operate profitably, service its debt, and fund upcoming operational expenses. Supply chain analytics can play a huge role in the active management of working capital. The focus on achieving a high-quality balance sheet requires granular level cost information at every point in the supply chain by product, by distribution channel, and by customer. Quantifying these cost differences can help a company discontinue an unprofitable product, alter a distribution network to increase profitability, and then redeploy the freed up capital towards new drug research or towards other innovations.